About Us
Fondazione Tech e Biomedical is a private foundation supervised by the Ministry of Enterprises and Made in Italy and the Ministry of Health
The aim of the Foundation is to:
Promote investments and initiatives in the fields of scientific research, economic development and technology transfer in favor of Italian start-ups and innovative SMEs that operate in the following macro-areas: green and circular economy, information technology, agri-tech and deep-tech.
Foster economic development of the Italian biomedical sector through initiatives aimed to link basic and preclinical research to clinical trial and production stages, creating highly specialized hubs, to improve the overall competitiveness and attractiveness towards investments, the ability to face health emergencies, to meet production needs, ultimately delivering a strong and innovative ecosystem. To achieve its purposes, Fondazione Tech e Biomedical manages the “Technology Transfer Fund” and the “Biomedical Research and Industrial Development Fund” on behalf of the Italian Ministry of Enterprises and Made in Italy, with an initial endowment of Euro 750 Millions.
President
Professor Cinzia Marchese
Since July 2026, he has been President of Fondazione Tech e Biomedical, where he leads a strategic organization for the development of technological innovation and research transfer in the biotech, pharmaceutical, and advanced health technology sectors.
At the helm of the Foundation, he brings his extensive scientific, academic, and institutional experience to the task of strengthening the connection between research, innovation, and the manufacturing system and fostering the transformation of Italy's scientific excellence into technologies, businesses, and solutions capable of generating value and impact for the country.
She is a Full Professor of Laboratory Medicine at Sapienza University of Rome and head of the Regenerative Medicine Service at the Policlinico Umberto I. An AIFA Qualified Person for advanced cell therapies, she has gained extensive experience in regenerative and translational medicine, stem cells, cell therapies, and innovative health technologies.
She has held important positions at MIMIT, MUR, the Ministry of Health, and ANVUR, contributing to national policies for research, innovation, and industrial development. She is an expert on industrial policies in the pharmaceutical and biomedical sectors at MIMIT and Coordinator of the MUR Committee for the Evaluation of the Three-Year Activity Plans of supervised entities.
His experience integrates science, institutions, healthcare, and industry, placing research and technology transfer at the heart of a strategic vision geared toward competitiveness, technological sovereignty, and the growth of the Italian innovation ecosystem.